tiprankstipranks
Advertisement
Advertisement
Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100
PremiumThe FlyInovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100
2M ago
Inovio Shareholders Endorse Governance Changes and Leadership
Premium
Company Announcements
Inovio Shareholders Endorse Governance Changes and Leadership
2M ago
Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze
Premium
Company Announcements
Inovio’s INO‑3107 Nears PDUFA Amid Cash Squeeze
2M ago
Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026
3M ago
Is INO a Buy, Before Earnings?
Premium
Pre-Earnings
Is INO a Buy, Before Earnings?
3M ago
Inovio Pharmaceuticals Announces New Public Equity Offering
Premium
Company Announcements
Inovio Pharmaceuticals Announces New Public Equity Offering
4M ago
Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
PremiumRatingsInovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
5M ago
Inovio reports Q4 EPS (26c), consensus (34c)
Premium
The Fly
Inovio reports Q4 EPS (26c), consensus (34c)
5M ago
Options Volatility and Implied Earnings Moves Today, March 12, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 12, 2026
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100